Follow

Submissions from 2011

Incidence and Outcome of Nontuberculous Mycobacterial Infection after Lung Transplantation, Shahzad Ahmad; Z, A. Bukhary; Oksana A. Shlobin; A. W. Brown; M. Schmidt; and Steven D. Nathan

A 10-Week Walking Program Improves Six-Minute Walk Distance and Cardiorespiratory Fitness in Patients With Pulmonary Hypertension, L Chan, M. Kennedy, J Woolstenhulme, G. Connors, Steven D. Nathan, N. Weir, L. Chin, and R. Keyser

Do CT Findings Correlate With the Phenomena fo "BOS" and "DeBOS/ReBOS in Lung Transplant Patients?", J. Collen; M. Fregoso; R. L. Brenner; A. W, Brown; Oksana A. Shlobin; Shahzad Ahmad; M. Lemma; and Steven D. Nathan

Congenital Absence of One Pulmonary Artery: An Uncommon Cause of Pulmonary Hypertension, J. Collen, Oksana A. Shlobin, A. W. Brown, N. Weir, Steven D. Nathan, and Shahzad Ahmad

Lung Size Mismatch in Bilateral Lung Transplantation Is Associated With Allograft Function and Bronchiolitis Obliterans Transplantation Is Associated With Allograft Function and Bronchiolitis Obliterans Syndrome, M. Eberlein, S. Permutt, R. M. Reed, S. Bolukbas, Steven D. Nathan, Oksana A. Shlobin, D. B. Pearse, H. E. Fessler, J. B. Orens, and R. G. Brower

Parameters of donor-recipient size mismatch and survival after bilateral lung transplantation, M. Eberlein, S. Permutt, R. M. Reed, S. Bolukbas, Steven D. Nathan, Oksana A. Shlobin, D. B. Pearse, H. E. Fessler, J. B. Orens, and R. G. Brower

“DeBos” and “ReBos”: When is a drop in the FEV1 really permanent?, M. M. Fergoso, R. L. Brenner, J. Collen, T. Reffett, A. W. Brown, Oksana A. Shlobin, Shahzad Ahmad, M. Lemma, and Steven D. Nathan

A Role For Thymosin-beta4 In Migration And Survival Of Idiopathic Pulmonary Fibrosis Fibroblasts, G. M. Grant, M.K. Chhina, J. Chang, Shahzad Ahmad, Oksana A. Shlobin, M. Lemma, R. Brenner, S. Khandhar, and Steven D. Nathan

Differential Human Beta Defensin Gene Expression in Idiopathic Pulmonary Fibrosis, S. Han, Steven D. Nathan, Shahzad Ahmad, G. M. Grant, and M. L. vanHoek

Utility of Immune Cell Function Assay Monitoring in Lung Transplant Recipients, S. Kilaru, A. W. Brown, Oksana A. Shlobin, Shahzad Ahmad, N. Weir, M. Fregoso, C. Athale, N. A. Burton, and Steven D. Nathan

Hemodynamic Predictors of Functional Ability in Patients with Idiopathic Pulmonary Fibrosis, A. Mazur, Oksana A. Shlobin, Nargues Weir, A. W. Brown, Shahzad Ahmad, S. D. Barnett, and Steven D. Nathan

A Multicenter, Retrospective Study of Patients With Pulmonary Arterial Hypertension Who Received Inhaled Iloprost for More Than One Year, J.W. McConnell, Steven D. Nathan, K. Hobbs, Desilu Vilanueva, Brian Hartline, and Robert Frantz

Montelukast for the Treatment of BOS Post-Lung Transplantation., I. A, Obi; A. W. Brown; Oksana A. Shlobin; Shahzad Ahmad; Nargues Weir; M. Fregoso; C. Athale; S. D. Burton; and Steven D. Nathan

Sildenafil to Tadalafil Transition in Patients with Pulmonary Arterial Hypertension: A Retrospective Review, Oksana A. Shlobin; A. W, Brown; Nargues Weir; M. Lemme; K. Brown; Shahzad Ahmad; and Steven D. Nathan

The HLA Class II Allele DRB1*1501 is Over-represented in Patients with Idiopathic Pulmonary Fibrosis, J. Xue, B. R. Gochuico, C. A. Feghali-Bostwick, I. Noth, Steven D. Nathan, G. Rosen, I. O. Rosas, K. Gibson, N. Kaminski, F. C. Sciurba, Y. Zhang, and S.R. Duncan